Associated Banc-Corp’s PTC Therapeutics PTCT Stock Holding History

Associated Banc-Corp’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-38	Closed	-$2K	–	1112
2020 Q1	$2K	Buy	+38	New	+$1.91K	﹤0.01%	659

Other funds holding PTCT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Associated Banc-Corp's PTCT Position: Q2 2020 in Review

Associated Banc-Corp sold out of PTC Therapeutics (PTCT) in Q2 2020, closing a stake of 38 shares — an estimated $2K sold.

Associated Banc-Corp first reported a position in PTCT in Q1 2020 and held it in 1 quarter. The position peaked at $2K in Q1 2020. 203 funds tracked by Wall St. Rank hold PTCT as of Q2 2020.

Associated Banc-Corp reported no remaining PTC Therapeutics position as of Q2 2020 after selling out during the quarter.
Associated Banc-Corp sold 38 PTC Therapeutics shares in Q2 2020, an estimated $2K.
Associated Banc-Corp first reported a position in PTC Therapeutics in Q1 2020 and held it in 1 quarter.
Associated Banc-Corp's PTC Therapeutics position peaked at $2K in Q1 2020.
203 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2020.

Based on Associated Banc-Corp's 13F filing for Q2 2020, filed 14 Aug 2020.